CNS PHARMACEUTICALS INC (CNSP) Stock Income Statement
NASDAQ:CNSP - Nasdaq - US18978H4092 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 15.70M | 14.90M | 18.87M | 15.27M | 14.49M | |||
| Research and Development | 10.10M | 9.29M | 14.10M | 9.30M | 9.81M | |||
| Selling, General, and Administrative Expenses | 5.59M | 5.61M | 4.77M | 5.97M | 4.68M | |||
| Operating Income | -15.70M | -14.90M | -18.87M | -15.27M | -14.49M | |||
| Interest Income/Expense | 80.40K | 44.10K | 13.90K | -10.00K | -10.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -15.61M | -14.86M | -18.85M | -15.27M | -14.50M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -15.61M | -14.86M | -18.85M | -15.27M | -14.50M | |||
| EBITDA | N/A | -14.90M | -18.86M | -15.26M | -14.48M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -358.52 | -38.87 | -12.48K | -28.28K | -41.43K | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | -40.50K | |||
| Statistics | ||||||||
All data in USD